Safety, Tolerability, and Pharmacodynamic Effect Study of PUR118

NCT01333904 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

90

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Obstructive Pulmonary Disease

Interventions

DRUG: PUR118

Sponsor

Pulmatrix Inc.

Collaborators

[object Object]